Exciting News from the Florida Institute | July Newsletter

Issue 56 - July 2017


Dominion Aesthetic Technologies Receives Institute Funding 
 
The Florida Institute has finalized a first-round funding agreement with Dominion Aesthetic Technologies, an Altamonte Springs-based company with technology developed at the University of Central Florida. Dominion Aesthetic Technologies is an innovative company focused on the commercialization of medical devices in the aesthetic field. The company is led by a team of industry experts whose mission is to advance the field of aesthetic medical devices by delivering products that are convenient and easy to use for clinicians and safe for patients. More details may be viewed here.

 




Florida Institute Portfolio Companies Experience
Record Revenue and Job Growth

Funded Company Progress Surpasses FY2016 Results

The Institute has compiled results from the fiscal year – ended June 30, 2017, and is pleased to announce that the companies it has funded achieved significant milestones last year as measured by the amount of seed and early stage investment capital raised, knowledge-based jobs created, regulatory approvals granted, and revenues generated. More details can be viewed here.
 



    

2017 BioFlorida Annual Conference Earlybird Registration
Ends Friday, 7/28

Register today for the BioFlorida 2017 Annual Conference being held on October 15-17, 2017 at the Vinoy Renaissance St. Petersburg Resort and Golf Club.  BioFlorida attracts the largest and most prestigious life sciences community in the state, and it is at this Conference that attendees will connect with more than 400 life science professionals from Florida and throughout the country. More details and event registration may be viewed here.



Intelligent Retinal Imaging Systems Raises Series B Growth Funding

IRIS, the industry leader in early detection systems for diabetic eye disorder, announced the company successfully closed a round of Series B financing. The round was led by Ballast Point Ventures, a later-stage venture capital and growth equity firm that invests in rapidly growing, privately owned companies in healthcare and technology industries. More details can be viewed here.

 



Paracosm Launches New Handheld Lidar Scanner

Gainesville-based Paracosm has created the PX-80, the world’s first mobile SLAM/LIDAR 3D scanner with color data. In a side-by-side comparison with the Faro Focus, the PX-80 proved to be 10x faster for total scanning time and 8.5x faster for overall workflow and post-processing. More details may be viewed here.
 


 


Colleges Get Proactive in Addressing Depression on Campus

Colleges and universities are increasingly focused on trying to understand, through rigorous research, what interventions work best and for the broadest swath of students. TAO Connect has partnered with Davidson University to begin a pilot project to assist students in need. More details may be viewed here.
 



Captozyme Among Florida Companies to Watch

Captozyme, a Gainesville-based biotechnology company, is among 50 statewide companies expected to see significant growth over the next several years. Captozyme was selected from more than 500 nominees for Florida Companies to WatchSM, a statewide program managed by economic development group GrowFL, in association with the Edward Lowe Foundation. More details may be viewed here.

 



Applications are Open for the 2018 Florida Venture Capital Conference
Apply Today to Present!
 

The Florida Venture Forum is now accepting applications to present at the 2018 conference and early submissions are welcomed and encouraged, as a limited number of presenter spots are available. These applications will be reviewed by a selection committee comprised of venture capitalists and private equity investors. If selected, presenting companies will be charged $599 for their first conference attendee and a $50 exhibit fee. To ensure optimum coverage, there is a discounted fee of $399 per additional attendee from the presenting company. More details and the application may be viewed here.


About Us

Formed by the Florida Legislature in 2007, the Florida Institute for the Commercialization of Public Research is a non-profit organization that works collaboratively with the technology licensing and commercialization offices of Florida’s state universities and private research institutions to leverage a $2.5B+ research base and form investable companies that create clean jobs in new industries that are driving the global economy. The Institute provides company building services, and seed funding through the Florida Technology Seed Capital Fund, to promising Florida startups. Seventy-two companies have been funded to date, and the Institute’s economic impact through June 30, 2016 was $630 million, with an annual return on investment of 22 times to the State of Florida. New data about FY16/17 results will be available soon.

 

Share

Facebook icon
Twitter icon
LinkedIn icon
Pinterest icon
e-mail icon